Literature DB >> 21503570

Overexpression of α1,6-fucosyltransferase in hepatoma enhances expression of Golgi phosphoprotein 2 in a fucosylation-independent manner.

Sayuri Kawamoto1, Kenta Moriwaki, Tsutomu Nakagawa, Mika Terao, Shinichiro Shinzaki, Naoko Yamane-Ohnuki, Mitsuo Satoh, Anand S Mehta, Timothy M Block, Eiji Miyoshi.   

Abstract

Golgi phosphoprotein 2 (GP73) is a type II Golgi protein, which was found on examination of the fucosylated proteome as a potential tumor marker for hepatocellular carcinoma (HCC). The serum levels of both total and fucosylated GP73 were increased in the sera of patients with HCC. Fucosylation is one of the most important oligosaccharide modifications involved in cancer and is catalyzed by α1,6-fucosyltransferase (Fut8). In the present study, we investigated the effect of Fut8 overexpression on GP73 production in the human hepatoma cell line Hep3B. The Fut8 expression vector was transfected into Hep3B cells and the expression of GP73 was investigated by Western blotting and real-time PCR. Overexpression of Fut8 dramatically enhanced the expression of GP73 at the transcriptional level. Surprisingly, this effect was not dependent on cellular fucosylation. Overexpression of a mutant Fut8, which was unable to be localized to the Golgi, did not induce GP73 production, suggesting that the localization of Fut8 in the Golgi apparatus was important for the increase in GP73 expression. This is the first demonstration of GP73 regulation through overexpression of a glycosyltransferase, which may lead to Golgi stress.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503570      PMCID: PMC3095700          DOI: 10.3892/ijo.2011.1005

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  24 in total

Review 1.  ER stress response, peroxisome proliferation, mitochondrial unfolded protein response and Golgi stress response.

Authors:  Hiderou Yoshida
Journal:  IUBMB Life       Date:  2009-09       Impact factor: 3.885

2.  GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.

Authors:  Jorge A Marrero; Patrick R Romano; Olga Nikolaeva; Laura Steel; Anand Mehta; Claus J Fimmel; Mary Ann Comunale; Anthony D'Amelio; Anna S Lok; Timothy M Block
Journal:  J Hepatol       Date:  2005-06-28       Impact factor: 25.083

3.  Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.

Authors:  Noriko Okuyama; Yoshihito Ide; Miyako Nakano; Tsutomu Nakagawa; Kanako Yamanaka; Kenta Moriwaki; Kohei Murata; Hiroaki Ohigashi; Shigekazu Yokoyama; Hidetoshi Eguchi; Osamu Ishikawa; Toshifumi Ito; Michio Kato; Akinori Kasahara; Sunao Kawano; Jianguo Gu; Naoyuki Taniguchi; Eiji Miyoshi
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

4.  Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice.

Authors:  Xiangchun Wang; Shinya Inoue; Jianguo Gu; Eiji Miyoshi; Katsuhisa Noda; Wenzhe Li; Yoko Mizuno-Horikawa; Miyako Nakano; Michio Asahi; Motoko Takahashi; Naofumi Uozumi; Shinji Ihara; Seung Ho Lee; Yoshitaka Ikeda; Yukihiro Yamaguchi; Yoshiya Aze; Yoshiaki Tomiyama; Junichi Fujii; Keiichiro Suzuki; Akihiro Kondo; Steven D Shapiro; Carlos Lopez-Otin; Tomoyuki Kuwaki; Masaru Okabe; Koichi Honke; Naoyuki Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-18       Impact factor: 11.205

5.  Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.

Authors:  Timothy M Block; Mary Ann Comunale; Melissa Lowman; Laura F Steel; Patrick R Romano; Claus Fimmel; Bud C Tennant; W Thomas London; Alison A Evans; Baruch S Blumberg; Raymond A Dwek; Tajinder S Mattu; Anand S Mehta
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-10       Impact factor: 11.205

6.  N-linked glycosylation of the liver cancer biomarker GP73.

Authors:  Pamela A Norton; Mary Ann Comunale; Jonathan Krakover; Lucy Rodemich; Natalie Pirog; Anthony D'Amelio; Ramila Philip; Anand S Mehta; Timothy M Block
Journal:  J Cell Biochem       Date:  2008-05-01       Impact factor: 4.429

Review 7.  Biological function of fucosylation in cancer biology.

Authors:  Eiji Miyoshi; Kenta Moriwaki; Tsutomu Nakagawa
Journal:  J Biochem       Date:  2008-01-24       Impact factor: 3.387

8.  A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.

Authors:  Kenta Moriwaki; Katsuhisa Noda; Takatoshi Nakagawa; Michio Asahi; Harumasa Yoshihara; Naoyuki Taniguchi; Norio Hayashi; Eiji Miyoshi
Journal:  Glycobiology       Date:  2007-09-20       Impact factor: 4.313

9.  Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.

Authors:  K Noda; E Miyoshi; N Uozumi; S Yanagidani; Y Ikeda; C Gao; K Suzuki; H Yoshihara; K Yoshikawa; K Kawano; N Hayashi; M Hori; N Taniguchi; M Yoshikawa
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

10.  GP73, a novel Golgi-localized protein upregulated by viral infection.

Authors:  R D Kladney; G A Bulla; L Guo; A L Mason; A E Tollefson; D J Simon; Z Koutoubi; C J Fimmel
Journal:  Gene       Date:  2000-05-16       Impact factor: 3.688

View more
  6 in total

1.  The SH3 domain in the fucosyltransferase FUT8 controls FUT8 activity and localization and is essential for core fucosylation.

Authors:  Seita Tomida; Misaki Takata; Tetsuya Hirata; Masamichi Nagae; Miyako Nakano; Yasuhiko Kizuka
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

Review 2.  FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer.

Authors:  Kayla Bastian; Emma Scott; David J Elliott; Jennifer Munkley
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

3.  Fucosylation Promotes Cytolytic Function and Accumulation of NK Cells in B Cell Lymphoma.

Authors:  Xing Tong; Yuhua Ru; Jianhong Fu; Ying Wang; Jinjin Zhu; Yiyang Ding; Fulian Lv; Menglu Yang; Xiya Wei; Chenchen Liu; Xin Liu; Lei Lei; Xiaojin Wu; Lingchuan Guo; Yang Xu; Jie Li; Peng Wu; Huanle Gong; Jia Chen; Depei Wu
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

4.  Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.

Authors:  Si-Cong Hou; Ming-Bing Xiao; Run-Zhou Ni; Wen-Kai Ni; Feng Jiang; Xiao-Yan Li; Cui-Hua Lu; Bu-You Chen
Journal:  Oncol Lett       Date:  2013-08-09       Impact factor: 2.967

5.  GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness.

Authors:  Kai Jiang; Wei Li; Qinle Zhang; Guoquan Yan; Kun Guo; Shu Zhang; Yinkun Liu
Journal:  Oncotarget       Date:  2016-04-26

Review 6.  Golgi protein 73 and its diagnostic value in liver diseases.

Authors:  Yanyan Xia; Yuanying Zhang; Mengjiao Shen; Hongpan Xu; Zhiyang Li; Nongyue He
Journal:  Cell Prolif       Date:  2018-10-19       Impact factor: 6.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.